@article{houot:hal-04059274,
TITLE = {Axicabtagene Ciloleucel As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Primary Analysis of Alycante, a Phase 2 Lysa Study},
AUTHOR = {Houot, Roch and Bachy, Emmanuel and Cartron, Guillaume and Gros, Fran{\c c}ois-Xavier and Morschhauser, Franck and Ob{\'e}ric, Lucie and Gastinne, Thomas and Feugier, Pierre and Dul{\'e}ry, R{\'e}my and Thieblemont, Catherine and Joris, Magalie and Llamas Gutierrez, Francisco and Itti, Emmanuel and M{\'e}nard, C{\'e}dric and Al Tabaa, Yassine and Bailly, Cl{\'e}ment and Delfau-Larue, Marie-H{\'e}l{\`e}ne and Laurent, Camille and Lemonnier, Fran{\c c}ois},
URL = {https://hal.science/hal-04059274},
JOURNAL = {Blood},
PUBLISHER = {American Society of Hematology},
VOLUME = {140},
NUMBER = {Supplement 1},
PAGES = {-},
YEAR = {2022},
MONTH = Nov, DOI = {10.1182/blood-2022-156626},
HAL_ID = {hal-04059274},
HAL_VERSION = {v1},
}